Items where authors include "Md Yusof, MY"

Article

Carter, LM orcid.org/0000-0002-8724-5937, Alase, A, Wigston, Z et al. (10 more authors) (2023) Gene expression and autoantibody analysis reveals distinct ancestry-specific profiles associated with response to rituximab in refractory systemic lupus erythematosus. Arthritis & Rheumatology, 75 (5). pp. 697-710. ISSN 2326-5191

Md Yusof, MY orcid.org/0000-0003-3131-9121, Arnold, J, Saleem, B et al. (5 more authors) (2023) Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study. The Lancet Rheumatology, 5 (2). e88-e98. ISSN 2665-9913

Robinson, JI orcid.org/0000-0001-5425-7520, Md Yusof, MY orcid.org/0000-0003-3131-9121, Davies, V et al. (20 more authors) (2022) Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity. eBioMedicine, 86. 104343. ISSN 2352-3964

Md Yusof, MY orcid.org/0000-0003-3131-9121, Alivernini, S and Chatzidionysiou, K (2022) Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases. Frontiers in Medicine, 9. ISSN 2296-858X

Pepple, S, Arnold, J, Vital, EM orcid.org/0000-0003-1637-4755 et al. (5 more authors) (2022) Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome. ACR Open Rheumatology, 4 (8). pp. 689-699. ISSN 2578-5745

Arnold, J, Vital, EM orcid.org/0000-0003-1637-4755, Dass, S et al. (5 more authors) (2022) A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis. Frontiers in Immunology, 12. 803175. ISSN 1664-3224

Md Yusof, MY orcid.org/0000-0003-3131-9121 and Vital, EM orcid.org/0000-0003-1637-4755 (2022) Early intervention in systemic lupus erythematosus: time for action to improve outcomes and health-care utilization. Rheumatology Advances in Practice, 6 (1). rkab106. ISSN 2514-1775

Mahmoud, K, Zayat, AS, Md Yusof, MY orcid.org/0000-0003-3131-9121 et al. (12 more authors) (2021) Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study. Rheumatology, 60 (11). pp. 5194-5204. ISSN 1462-0324

Hassan, SU, Md Yusof, MY, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2020) Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab. Frontiers in Medicine, 7. 498. ISSN 2296-858X

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Md Yusof, MY orcid.org/0000-0003-3131-9121, Psarras, A et al. (11 more authors) (2020) B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus. Arthritis & Rheumatology, 72 (5). pp. 769-779. ISSN 2326-5191

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, McElvenny, DM et al. (7 more authors) (2019) Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases. Arthritis & Rheumatology, 71 (11). pp. 1812-1823. ISSN 2326-5191

Md Yusof, MY orcid.org/0000-0003-3131-9121, Britton, J, Edward, S et al. (6 more authors) (2019) Validity and sensitivity to change of laser Doppler imaging as a novel objective outcome measure for cutaneous lupus erythematosus. Lupus, 28 (11). pp. 1320-1328. ISSN 0961-2033

Shalbaf, M, Alase, AA, Berekmeri, A et al. (8 more authors) (2019) Plucked hair follicles from patients with chronic discoid lupus erythematosus show a disease-specific molecular signature. Lupus Science and Medicine, 6 (1). e000328. ISSN 2053-8790

Md Yusof, MY orcid.org/0000-0003-3131-9121, Psarras, A, El-Sherbiny, YM orcid.org/0000-0003-4791-3475 et al. (9 more authors) (2018) Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status. Annals of the Rheumatic Diseases, 77 (10). pp. 1432-1439. ISSN 0003-4967

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, El-Sherbiny, Y orcid.org/0000-0003-4791-3475 et al. (4 more authors) (2017) Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus. Annals of the Rheumatic Diseases, 76 (11). pp. 1829-1836. ISSN 0003-4967

Md Yusof, MY orcid.org/0000-0003-3131-9121, Kabia, A, Darby, M et al. (5 more authors) (2017) Effect of rituximab on the progression of rheumatoid arthritis–related interstitial lung disease: 10 years’ experience at a single centre. Rheumatology, 56 (8). pp. 1348-1357. ISSN 1462-0324

Bissell, L-A orcid.org/0000-0002-2789-4652, Md Yusof, MY orcid.org/0000-0003-3131-9121 and Buch, MH orcid.org/0000-0002-8962-5642 (2017) Primary myocardial disease in scleroderma – a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group. Rheumatology, 56 (6). pp. 882-895. ISSN 1462-0324

Zayat, AS, Md Yusof, MY, Wakefield, RJ et al. (3 more authors) (2016) The role of ultrasound in assessing musculoskeletal symptoms of systemic lupus erythematosus: a systematic literature review. Rheumatology, 55 (3). pp. 485-494. ISSN 1462-0324

Md Yusof, MY, Vital, EM and Buch, MH (2015) B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During Use. Current Rheumatology Reports, 17 (10). 65. ISSN 1523-3774

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, Das, S et al. (5 more authors) (2015) Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions. Annals of the Rheumatic Diseases, 74 (9). pp. 1734-1738. ISSN 0003-4967

Vital, EM orcid.org/0000-0003-1637-4755, Wittmann, M orcid.org/0000-0003-2328-4926, Edward, S et al. (5 more authors) (2015) Brief report: Responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus. Arthritis and Rheumatology, 67 (6). pp. 1586-1591. ISSN 2326-5191

Vital, EM, Md Yusof, MY and Emery, P (2014) Choosing the right rituximab dose for the right patient: Comment on the article by Bredemeier et al. Arthritis Care and Research, 66 (10). 1591 - 1593. ISSN 2151-464X

Md Yusof, MY, Vital, EM and Emery, P (2014) Biologics in systemic lupus erythematosus: current options and future perspectives. British Journal of Hospital Medicine, 75 (8). 440 - 447. ISSN 1750-8460

Fechtenbaum, M, Md Yusof, MY and Emery, P (2014) Certolizumab pegol in rheumatoid arthritis: Current update. Expert Opinion on Biological Therapy, 14 (6). 841 - 850. ISSN 1471-2598

Arumugakani, G, Vital, EM, Md Yusof, MY et al. (2 more authors) (2014) Response to: 'Which B-cell subset should we target in lupus?' By Ferraccioli and Houssiau. Annals of the Rheumatic Diseases, 73 (4). e20. ISSN 0003-4967

Md Yusof, MY, Vital, EM and Emery, P (2013) B-cell-targeted therapies in systemic lupus erythematosus and ANCA-associated vasculitis: Current progress. Expert Review of Clinical Immunology, 9 (8). 761 - 772. ISSN 1744-666X

Md Yusof, MY and Emery, P (2013) Targeting interleukin-6 in rheumatoid arthritis. Drugs, 73 (4). 341 - 356. ISSN 0012-6667

Conference or Workshop Item

Md Yusof, MY orcid.org/0000-0003-3131-9121, Robinson, J, El-Sherbiny, Y et al. (4 more authors) (2019) SAT0009 THE EFFECT OF FCGR3A POLYMORPHISM ON THE INITIAL DEPTH OF B-CELL DEPLETION BY RITUXIMAB, FUNCTIONAL NK-CELL MEDIATED KILLING AND CLINICAL RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS. In: Annual European Congress of Rheumatology, EULAR 2019, 12-15 Jun 2019, Madrid, Spain.

Dutton, K, Psarras, A, El-Sherbiny, Y orcid.org/0000-0003-4791-3475 et al. (3 more authors) (2018) OP0124 In sle patients in sustained low disease activity, novel interferon assays predict flares and glucocorticoid requirements. In: Annual European Congress of Rheumatology, EULAR 2018, 13-16 Jun 2018, Amsterdam, Netherlands.

Giollo, A, Gandrala, S, Vojinovic, T et al. (5 more authors) (2018) THU0136 Major cardiovascular events in 434 rheumatoid arthritispatients treated with rituximab from a single-centre. In: Annual European Congress of Rheumatology, EULAR 2018, 13-16 Jun 2018, Amsterdam, Netherlands.

Proceedings Paper

Carter, LM, Alase, A, Wigston, Z et al. (8 more authors) (2022) OA09 Gene expression analysis reveals distinct ancestry-specific profiles associated with response to rituximab in SLE. In: Rheumatology. UNSPECIFIED. Oxford University Press , i4-i5.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Britton, J, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (4 more authors) (2017) Laser doppler imaging: an objective outcome measure for assessment of cutaneous lupus erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , pp. 1019-1020.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, El-Sherbiny, YM orcid.org/0000-0003-4791-3475 et al. (3 more authors) (2017) Predicting and managing primary and secondary non-response to rituximab using b-cell biomarkers in systemic lupus erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 869.

Md Yusof, MY orcid.org/0000-0003-3131-9121, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Psarras, A et al. (6 more authors) (2017) Prediction of connective tissue disease in an at-risk cohort using a novel interferon stimulated gene expression score. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 91.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, McElvenny, D et al. (5 more authors) (2017) Risk factors for severe infection and rationale for immunoglobulin monitoring during rituximab treatment in autoimmune rheumatic diseases. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 987.

Mahmoud, K, Zayat, A, Edwards, CJ et al. (5 more authors) (2016) An Evaluation of Clinical Outcome Measures for Musculoskeletal Lupus Using Ultrasound as A Gold Standard: Table 1. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ PUblishing Group , p. 556.

Zayat, AS, Mahmoud, K, Md Yusof, MY orcid.org/0000-0003-3131-9121 et al. (4 more authors) (2016) A Prospective Study To Assess Responsiveness of Clinical and Ultrasound Outcome Measures for Musculoskeletal Sle. In: Annals of the Rheumatic Diseases. Annual European Conference of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 549.

El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Md Yusof, MY orcid.org/0000-0003-3131-9121, Hensor, E orcid.org/0000-0002-5245-4755 et al. (3 more authors) (2016) Surface Tetherin Is A Novel Cell-Specific Biomarker for Interferon Response in Systemic Lupus Erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 546.

Mohamed, AAA, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (6 more authors) (2016) Type I Interferon Activity Is Associated with Mucocutaneous but Not Musculoskeletal Disease Activity in Systemic Lupus Erythematosus:. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 547.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Iqbal, K, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2016) Efficacy and Safety of Rituximab in Patients with Rheumatoid Arthritis-Related Bronchiectasis (RA-BR): Results from A Multicentre Cohort. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 996.

Md Yusof, MY orcid.org/0000-0003-3131-9121, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Psarras, A et al. (4 more authors) (2016) Incomplete and Systemic Lupus Erythematosus Reveal A Different Pattern of Interferon-Stimulated Genes Up-Regulation. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , pp. 285-286.

Md Yusof, MY, Hensor, EM, Das, S et al. (3 more authors) (2016) Risk Factors for Severe Infection and Outcome of Secondary Hypogammaglobulinaemia in Patients with Autoimmune Rheumatic Diseases Treated with Rituximab: Preliminary Results from 400 Patients at A Single Centre. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 845.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Candelier, JB, Dass, S et al. (3 more authors) (2016) Validation of B Cell Depletion as A Predictor of Clinical Response and Efficacy of Retreatment of Non-Response in Rheumatoid Arthritis. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 731.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, Rawstron, A et al. (2 more authors) (2016) Validation of Highly Sensitive Flow Cytometry as A Biomarker for Rituximab in Sle: A Rationale for More Intensive Treatment To Improve Clinical Outcomes. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 296.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Cassamoali, H, Rawstron, AC et al. (4 more authors) (2016) Humanized Anti-CD20 Antibodies Improve Depletion and Response in Systemic Lupus Erythematosus Patients with Resistance to Rituximab: Results from the First 100 Patients at a Single Centre. In: Rheumatology. Rheumatology 2016, 26-28 Apr 2016, Glasgow, UK. Oxford University Press , i46-i47.